Initial Management Plan for Bronchial Asthma
The recommended initial management plan for bronchial asthma includes inhaled corticosteroids as the cornerstone of therapy, with short-acting beta-agonists for symptom relief, and a written self-management plan for the patient. 1
Assessment and Classification
- Assess severity of asthma based on symptoms, peak expiratory flow (PEF), and response to previous treatment 1
- Classify asthma as mild, moderate, or severe based on clinical features:
Initial Pharmacological Management
For Mild to Moderate Persistent Asthma:
- Start with inhaled corticosteroids (up to 800 μg/day equivalent of beclomethasone) as the primary anti-inflammatory therapy 1, 2
- Prescribe short-acting inhaled beta2-agonist (e.g., salbutamol) as needed for symptom relief 1
- Consider adding long-acting beta2-agonists if symptoms persist despite adequate doses of inhaled corticosteroids 1, 3
For Acute Severe Asthma:
- Administer oxygen 40-60% (oxygen therapy is not contraindicated in asthma) 1
- Give nebulized salbutamol 5-10 mg or terbutaline 5-10 mg via oxygen-driven nebulizer 1
- Administer oral prednisolone 30-60 mg or intravenous hydrocortisone 200 mg 1
- Consider adding ipratropium bromide 0.5 mg to nebulizer if patient is not improving after 15-30 minutes 1
Monitoring and Follow-up
- Measure PEF before and after bronchodilator administration to assess response 1
- Maintain oxygen saturation >92% using pulse oximetry 1
- Schedule follow-up within one week with primary care physician after any acute episode 1
- Arrange follow-up with respiratory specialist within 4 weeks if hospitalized 1
Patient Education and Self-Management
- Provide a written asthma action plan detailing:
- When to increase treatment
- When to seek medical help
- How to adjust medications based on symptoms and PEF readings 1
- Prescribe a peak flow meter and teach proper technique 1
- Educate about proper inhaler technique and check at each visit 1
- Identify and avoid triggers (allergens, smoking, etc.) 1
Medication Delivery Devices
- Start with metered dose inhaler (MDI) for most patients 1
- Add large volume spacer if patient has difficulty using MDI alone 1
- Consider dry powder or automatic aerosol inhaler if patient finds MDI with spacer difficult to carry 1
Special Considerations
- Avoid sedatives in patients with asthma attacks 1
- Consider chest radiograph to exclude pneumothorax in severe cases 1
- For children: adjust medication doses appropriately (half doses of nebulized medications for very young children) 1
- Monitor growth in pediatric patients on long-term inhaled corticosteroids 4
Common Pitfalls to Avoid
- Underestimating severity: Any features of severe asthma should alert the clinician, even if the patient does not appear distressed 1
- Inadequate follow-up: All patients require monitoring after an acute episode 1
- Poor inhaler technique: Check and document proper technique at each visit 1
- Overreliance on bronchodilators: If using more than one canister of short-acting beta-agonist per month, increase controller therapy 1
- Failure to provide a written action plan: All patients should have a written self-management plan 1
By following this structured approach to asthma management, focusing on both anti-inflammatory therapy and bronchodilation as needed, most patients can achieve good symptom control and minimize exacerbations.